Literature DB >> 9769619

Presenting symptoms in patients referred to a multidisciplinary clinic for bone metastases.

N A Janjan1, R Payne, T Gillis, D Podoloff, H I Libshitz, R Lenzi, R Theriault, C Martin, A Yasko.   

Abstract

Symptom control is the goal of palliative irradiation. Approximately 1 month is required before symptomatic relief is accomplished with radiotherapy. However, many patients with cancer-related pain do not receive adequate analgesics, and opioids are often not prescribed until patients fail to respond to palliative irradiation. The presenting symptoms of 108 patients who were referred to a multidisciplinary clinic for bone metastases were evaluated with the Wisconsin Brief Pain Inventory (BPI). This validated instrument evaluates the severity of pain using a 0-10 scale; 10 represents the worst pain imaginable. The population comprised 65 men (60%) and 43 women whose ages ranged from 33 years to 81 years; median age was 55 years, and 69% of patients were less than 65 years of age. Despite the presence of metastatic disease, 21% of patients were working full-time outside the home, and 6% were employed part-time outside the home; 13% were homemakers. Only 17 patients (16%) were unemployed. The time since diagnosis ranged from 2 weeks to 23 years; the median time since diagnosis was 22 months, and 30% of patients had been diagnosed with the past 6 months. Pain was a presenting symptom in 74% (N = 80) of patients at diagnosis. At its worst, the pain was rated as severe (levels 7-10) by 78% and intolerable (level 10) in 22% of the patients in the 24 hr prior to the clinic appointment. On average, the pain was rated moderate to severe (levels 4-10) in 79% and severe in 23% of patients. Only 45% of patients experienced good relief from the prescribed analgesics, and 23% of patients indicated that the prescribed analgesics were ineffective. This survey demonstrates that bone metastases incur significant pain that is often undertreated with analgesics before antineoplastic therapy is administered.

Entities:  

Mesh:

Year:  1998        PMID: 9769619     DOI: 10.1016/s0885-3924(98)00069-4

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  12 in total

1.  Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: a phase 1-2 trial.

Authors:  Xin Shelley Wang; Laurence D Rhines; Almon S Shiu; James N Yang; Ugur Selek; Ibrahima Gning; Ping Liu; Pamela K Allen; Syed S Azeem; Paul D Brown; Hadley J Sharp; David C Weksberg; Charles S Cleeland; Eric L Chang
Journal:  Lancet Oncol       Date:  2012-01-27       Impact factor: 41.316

2.  CORR Insights®: Can We Estimate Short- and Intermediate-term Survival in Patients Undergoing Surgery for Metastatic Bone Disease?

Authors:  Michelle Ghert
Journal:  Clin Orthop Relat Res       Date:  2016-12-19       Impact factor: 4.176

Review 3.  Percutaneous tumor ablation with radiofrequency.

Authors:  Bradford J Wood; Jeffrey R Ramkaransingh; Tito Fojo; McClellan M Walther; Stephen K Libutti
Journal:  Cancer       Date:  2002-01-15       Impact factor: 6.860

4.  Attitudes of radiation oncologists toward palliative and supportive care in the United States: Report on national membership survey by the American Society for Radiation Oncology (ASTRO).

Authors:  Randy L Wei; Malcolm D Mattes; James Yu; Adrienne Thrasher; Hui-Kuo Shu; Harald Paganetti; Jennifer De Los Santos; Bridget Koontz; Christopher Abraham; Tracy Balboni
Journal:  Pract Radiat Oncol       Date:  2016-09-07

5.  Palliation of soft tissue cancer pain with radiofrequency ablation.

Authors:  Julia K Locklin; Andrew Mannes; Ann Berger; Bradford J Wood
Journal:  J Support Oncol       Date:  2004 Sep-Oct

6.  Beyond palliative radiotherapy: a pilot multidisciplinary brain metastases clinic.

Authors:  Brita Danielson; Alysa Fairchild
Journal:  Support Care Cancer       Date:  2011-04-09       Impact factor: 3.603

Review 7.  Skeletal metastases from breast cancer: pathogenesis of bone tropism and treatment strategy.

Authors:  Caterina Fontanella; Valentina Fanotto; Karim Rihawi; Giuseppe Aprile; Fabio Puglisi
Journal:  Clin Exp Metastasis       Date:  2015-09-07       Impact factor: 5.150

8.  Effects of skeletal morbidities on longitudinal patient-reported outcomes and survival in patients with metastatic prostate cancer.

Authors:  Venita DePuy; Kevin J Anstrom; Liana D Castel; Kevin A Schulman; Kevin P Weinfurt; Fred Saad
Journal:  Support Care Cancer       Date:  2007-07       Impact factor: 3.359

9.  A multidisciplinary bone metastases clinic at Toronto Sunnybrook Regional Cancer Centre - A review of the experience from 1999 to 2005.

Authors:  Kathy K Li; Emily Sinclair; Joan Pope; Macey Farhadian; Kristin Harris; Julie Napolskikh; Albert Yee; Lawrence Librach; Lesia Wynnychuk; Cyril Danjoux; Edward Chow; On Behalf Of The Bone; Metastases Team
Journal:  J Pain Res       Date:  2008-09-01       Impact factor: 3.133

Review 10.  AAPT Diagnostic Criteria for Chronic Cancer Pain Conditions.

Authors:  Judith A Paice; Matt Mulvey; Michael Bennett; Patrick M Dougherty; John T Farrar; Patrick W Mantyh; Christine Miaskowski; Brian Schmidt; Thomas J Smith
Journal:  J Pain       Date:  2016-11-21       Impact factor: 5.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.